Metagenomi to Present New Data for Its Novel Gene-Editing Systems at the 26th American Society of Gene + Cell Therapy (ASGCT) Annual Meeting

EMERYVILLE, Calif.–(BUSINESS WIRE)–Metagenomi, a genetic medicines company with a versatile portfolio of wholly owned, next-generation gene editing systems, announced it will present new data during the 26th American Society of Gene + Cell Therapy (ASGCT) Annual Meeting in Los Angeles (May 16-20). “As we advance the field of genetic medicines,…